Cannabinoid receptor 1 (CB1) is the principal target of ?(9)-tetrahydrocannabinol (THC), a psychoactive chemical from Cannabis sativa with a wide range of therapeutic applications and a long history of recreational use. CB1 is activated by endocannabinoids and is a promising therapeutic target for pain management, inflammation, obesity, and substance abuse disorders.
New research suggests Cannabinoid Receptor Type 2 a potential target for SARS-CoV-2 infection. Learn more: LINK
For international customers outside the US, please visit the model on our 3D printing service’s international website: LINK
3D model created from PDB ID: 5tgz